Speciality: Blood Transfusion
Location: South East Coast
Speciality: Medical Lab Assistant
A new vaccine could protect against tuberculosis (TB), after showing promise in a mouse study.
Research published in journal Nature Medicine found that a vaccine composed of genetically modified bacterium closely related to the bacterium that causes TB.
Scientists genetically modified M. Smegmatis - a relative of Mtb that is more or less harmless to humans.
They replaced a set of the bacterium's genes called esx-3 with corresponding but not identical genes from Mtb.
Mice who were vaccinated with the substance carried 1,000 times less the levels of TB bacteria and their counterparts who received bacille Calmette-Guerin (BCG) - a widely available vaccine for the disease.
This follows news of a pancreatic cancer vaccine, known as GV1001, which is being trialled at the Royal Liverpool University Hospital.
GV1001 is designed to work by teaching the immune system to attack cancer cell and could help people to recover from the condition.
Posted by Martin Lambert
A fresh injection of funds from the Medical Research Council could mark positive news for those in biomedical...
A new discovery about the origins of tumours could help lead to better tests to diagnose cancer, as well as improved...
A new biomarker discovery has allowed researchers to develop a way to accurately detect early stage pancreatic...
Researchers believe that a new blood test could help distinguish between a bruised head and people who are at risk...